# Prospective, Double Blind, Placebo Control, Bariatric IV Ace

> **NCT02452320** · PHASE4 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 136 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** intravenous acetaminophen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02452320
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2018-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02452320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02452320, "Prospective, Double Blind, Placebo Control, Bariatric IV Ace". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02452320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*